相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009
D. E. Furst et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Nontuberculous Mycobacterial Disease Prevalence and Risk Factors: A Changing Epidemiology
P. Maureen Cassidy et al.
CLINICAL INFECTIOUS DISEASES (2009)
Preventing and treating biologic-associated opportunistic infections
Kevin L. Winthrop et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Nontuberculous Mycobacteria Infections and Anti-Tumor Necrosis Factor-α Therapy
Kevin L. Winthrop et al.
EMERGING INFECTIOUS DISEASES (2009)
Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: Case finding through the emerging infections network
Kevin L. Winthrop et al.
CLINICAL INFECTIOUS DISEASES (2008)
Veteran's affairs hospital discharge databases coded serious bacterial infections accurately
Sebastian Schneeweiss et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Antirheumatic drugs and the risk of tuberculosis
Paul Brassard et al.
CLINICAL INFECTIOUS DISEASES (2006)
Tumor necrosis factor and its blockade in granulomatous infections: Differential modes of action of infliximab and etanercept?
S Ehlers
CLINICAL INFECTIOUS DISEASES (2005)
Pharmacy data for tuberculosis surveillance and assessment of patient management
DS Yokoe et al.
EMERGING INFECTIOUS DISEASES (2004)
Granulomatous infectious diseases associated with tumor necrosis factor antagonists
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management
MA Gardam et al.
LANCET INFECTIOUS DISEASES (2003)
The epidemiology of rheumatoid arthritis
SE Gabriel
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2001)